Detailed neuropathological information on the structural brain lesions underlying seizures is valuable for understanding drug-resistant focal epilepsy.
Findings in Br ain Tissue Obtained during Epilepsy Surgery
I n 2015, the World Health Organization (WHO) recognized epilepsy as a serious public health concern. Approximately 50 million people worldwide currently have epilepsy, 1 and more than 30% of patients with epilepsy have inadequate seizure control with drug therapy. 2, 3 Epilepsy surgery is appropriate for carefully selected patients with difficult-to-treat focal epilepsy, [4] [5] [6] and successful epilepsy surgery reduces mortality in this population. 7 Although the efficacy of epilepsy surgery has been established in retrospective series from tertiary epilepsy centers, [8] [9] [10] [11] [12] [13] few of these studies have extensively explored the types of underlying pathologic brain lesions.
The European Epilepsy Brain Bank (EEBB) was established in 2006 under the direction of the Framework Program of the European Union to standardize histopathological reporting of specimens obtained during epilepsy surgery and to survey epileptogenic brain lesions. The EEBB collects a prespecified minimal data set of deidentified clinicopathological information for its database in accordance with this plan. The inception of the database also prompted the International League against Epilepsy (ILAE) to develop an international classification of clinicopathological subtypes of focal cortical dysplasia 14 and of subtypes of hippocampal sclerosis. 15 These standardized consensus classifications of specimens obtained during epilepsy surgery inform the study of epilepsy, which had previously relied on clinical series and small randomized trials for data on the underlying causes of seizures. [4] [5] [6] We present the histopathological diagnoses from the large EEBB database to complement existing information on drug-resistant epilepsy and epilepsy surgery.
Me thods

Study Procedures
We examined specimens from the EEBB database, which includes 4944 men and 4579 women with surgically treated epilepsy who underwent surgery during the period from 1990 through 2014 in 36 specialized epilepsy surgery centers in Austria, the Czech Republic, France, Germany, Greece, Italy, the Netherlands, Portugal, Spain, Switzerland, Turkey, and the United Kingdom (Table S1 in the Supplementary Appendix, available with the full text of this article at NEJM.org). Histopathological review of resected brain tissue was performed at local epilepsy centers and at the German Neuropathology Reference Center for Epilepsy Surgery in Erlangen, Germany. There was no systematic verification of diagnoses among centers, but the material was interpreted by experienced neuropathologists. For patients who underwent two or more resections, we used clinical data and histopathological diagnoses from the last surgical procedure. Before surgery, all patients had undergone a detailed clinical examination, electroencephalographic (EEG) investigation, and magnetic resonance imaging (MRI) of the head. Video EEG, neuropsychological and psychiatric testing, and functional imaging or invasive EEG were performed when clinically indicated and as was customary for each center.
The study was approved by the ethics review board of the University of Erlangen, and all procedures were conducted in accordance with the ethics requirements of the contributing centers. Written informed consent for the use of histopathological data was obtained from patients or their representative. Participating centers submitted the histopathological diagnosis of each specimen with a prespecified minimal clinical data set that included the patient's age at the onset of epilepsy, the patient's age at the time of surgery (with children defined as patients whose age was <18 years), duration of epilepsy before surgery (with dates rounded to whole year numbers), sex, side of lesion (left, right, or midline [i.e., hypothalamus]), location of the lesion (temporal, frontal, parietal, occipital, multilobar [including hemispheric], or midline [i.e., hypothalamus]), year of surgery, and histopathological diagnosis based on light-microscopic inspection of paraffin-embedded tissue stained with hematoxylin and eosin or additional histochemical staining and immunohistological methods when indicated. 16 Hippocampal sclerosis was defined histopathologically as segmental neuronal cell loss in anatomical sectors of the cornu ammonis of the hippocampus, as specified in the consensus classification of the ILAE. 15 Brain tumors were classified according to the WHO classification of tumors of the central nervous system. 17 Focal cortical dysplasia was defined according to the consensus classification system of the ILAE. 14 A post hoc analysis of associations between histopathological diagnoses and the outcome of surgery was performed for a subset of the centers. We classified patients as seizure-free or not seizure-free on the basis of information obtained 12 months after surgery. Freedom from seizures corresponded to category IA in the Engel clas- ) and was equivalent to category 1 in the ILAE classification system (scores range from 1 [completely seizure-free with no auras] to 6 [>100% increase in seizure days from baseline] 19 ).
Statistical Analysis
We analyzed differences among the seven histopathological categories in age at onset of seizures (<18 years vs. ≥18 years) and the side of the affected hemisphere, which resulted in 28 tests; we used Bonferroni adjustment with P≤0.0017 (i.e., P<[0.05 ÷ 28]) considered to indicate statistical significance. 20 Differences between groups were assessed with the use of an independentsample t-test for continuous variables and a chisquare test for categorical data. Results that are not accompanied by statistical analyses are descriptive only of numerical differences between groups. Statistics were analyzed with the use of SPSS Statistics 23 (IBM).
R esult s
Patients and Specimens
Resected brain tissue for histopathological review was available for 3901 patients (41.0%) at local epilepsy centers and for 5622 patients (59.0%) at the German Neuropathology Reference Center for Epilepsy Surgery in Erlangen, Germany. A total of 367 patients (3.8%) underwent two or more resections; for these patients, we used clinical data and histopathological diagnoses from the last surgical procedure. The prespecified minimal clinical data set was 97.5% complete for the overall series, with 1936 data points missing, in most cases for side of surgery, year of surgery, or anatomical localization. Of the 36 centers, 20 reported seizure outcomes after surgery for 85.2 to 100.0% of their patients, and these data were used for the post hoc analysis of associations between histopathological diagnoses and the outcome of surgery. Information on seizure outcomes from these 20 centers was available for 5248 patients at 1 year after surgery and for an additional 1920 patients at 24 months; this sample represented 98.4% of the 7286 patients for whom any outcome data were available, or 75.3% of the total patients in the series. In the 20 centers from which information was used for post hoc analysis of surgical outcomes, antiepileptic drug treatment was continued after surgery in all adults and in more than 90% of children.
At the time of surgery, 6900 (72.5%) of the patients were adults and 2623 (27.5%) were children. A total of 51.9% of patients were male (Table 1) . Seizure onset occurred in childhood (<18 years of age) in 75.9% of the patients, and seizures started earlier than 6 years of age in 36%. The region operated on was the temporal lobe in 71.9% of the patients. Surgical resection was performed on the left side of the brain in 49.1% of the patients, on the right side in 50.5%, and on midline structures in the remainder.
There were 36 histopathological diagnoses ( Table 2, and Tables S2 through S4 in the Supplementary Appendix) that could be classified into seven major conventional categories ( Table 3 ). The 10 most frequent histopathological diagnoses accounted for 86.7% of cases. Among the 7168 patients for whom reporting of postsurgical outcome was available, post hoc analysis indicated that 60.7% (66.4% of children and 58.6% of adults) were seizure-free 1 year after surgery (ILAE score of 1, Engel class IA).
Hippocampal Sclerosis
Hippocampal sclerosis was the most common histopathological diagnosis; this condition was identified in 36.4% of all surgical specimens -
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All patients (N = 9523) (Table 3, and Tables S3 and S4 in the Supplementary Appendix). Hippocampal sclerosis was diagnosed in 54.4% of specimens obtained from the temporal lobe (Fig. 1A, 1B , and 1C). 15 A second histopathological diagnosis was made in 1.5% of specimens with hippocampal sclerosis, including ganglioglioma (25.2%), glial scars (23.7%), focal cortical dysplasia (8.6%), dysembryoplastic neuroepithelial tumors (8.6%), encephalitis (7.2%), and cavernous angioma (5.8%). The duration of epilepsy before surgery in patients with hippocampal sclerosis is shown in Table S5 in the Supplementary Appendix. The onset of epilepsy was slightly but significantly earlier among patients with left hippocampal sclerosis than among those with right hippocampal sclerosis (mean age [±SD], 10.7±9.8 vs. 11.9±10.2 years; P<0.001). A relationship between the age at the onset of seizures and the side of the affected hemisphere was not found for any other histopathological category. Overall, the rate of freedom from seizures 1 year after surgery was 61.4% among patients who had the diagnosis of hippocampal sclerosis.
Tumors
Brain tumors were the second most common histopathological diagnosis, occurring in 23.6% of specimens, with ganglioglioma ( Fig. 1D, 1E , and 1F) being the most frequent (found in 10.4% of all patients in the study population). A total of 82.5% of gangliogliomas were located in the temporal lobe. Dysembryoplastic neuroepithelial tumors were the second most frequent type of tumor (5.9% of patients); in 68.1% of cases, this tumor was located in the temporal lobe. Early seizure onset occurred in association with both types of tumor, with a mean age (±SD) at onset of 13.1±10.7 years. Other tumors associated with an onset of epilepsy that occurred mainly before 18 years of age were angiocentric glioma, gangliocytoma, isomorphic astrocytoma, pilocytic astrocytoma, neurocytoma, and pleomorphic xanthoastrocytoma, as well as low-grade neuroepithelial tumors, the detailed characteristics of which were not further specified by the neuropathologist. Most of these tumors were classified as low grade (WHO grade I), and together with gangliogliomas and dysembryoplastic neuroepithelial tumors they accounted for 79.2% of all tumors in this series. One year after surgery, 68.4% of patients with tumors (79.9% of children and 63.5% of adults) were seizure-free.
Malformations of Cortical Development
Malformations of cortical development were found in 19.8% of specimens and were the third Table S2 in the Supplementary Appendix. † Data are the lobe in which surgery was most commonly performed for each condition and the percentage of cases in which surgery was performed in that lobe.
Table 2. Summary of the 10 Most Common Histopathological Diagnoses among 9523 Patients Who Underwent Epilepsy Surgery.*
T h e ne w e ngl a nd jou r na l o f m e dicine most frequent histopathological category; such malformations were identified in 39.3% of all specimens obtained from children. Subtypes of focal cortical dysplasia were the most common malformations of cortical development, accounting for 70.6% of cases. These malformations were characterized by architectural and cytoarchitectural abnormalities of the six layers of the cerebral cortex. The combination of dysmorphic neurons and balloon cells, which is characteristic of focal cortical dysplasia type II (Fig. 1G,  1H , and 1I), was the most common subtype of malformation (accounting for 45.3% of cases) and was present in 17.0% of all children in the series at the time of surgery (Table S4 in the Supplementary Appendix); this malformation was most often located in the frontal lobe (51.6%). The onset of epilepsy in patients with malformations of cortical development was earlier than that among patients with other disease categories (Table 3) . Within this group, multilobar malformations were associated with the earliest onset of epilepsy; patients with hemimegalencephaly had a mean age (±SD) at onset of seizures of 0.1±0.7 years, patients with multilobar focal cortical dysplasia type II a mean age at onset of 2.3±4.3 years, and patients with polymicrogyria a mean age at onset of 3.3±5.5 years. Among the 367 patients who had two or more surgical resections, cortical malformations (32.2%) and tumors (26.4%) were the most common conditions. Overall, 57.6% of patients with malformations of cortical development (59.9% of children and 54.6% of adults) were seizure-free 1 year after surgery.
No Lesion
No specific lesion could be identified or characterized by means of microscopic inspection in 7.7% of patients (8.4% of adults and 6.1% of children). This included findings of nonspecific reactive gliosis as the only histopathologic abnormality in the neocortex, white matter, or hippocampus. [14] [15] [16] Freedom from seizures 1 year after surgery occurred in 50.2% of patients in this category (55.2% of children and 48.7% of adults).
Vascular Lesions, Glial Scars, and Encephalitis
Vascular malformations were found in 6.1% of specimens, with cavernous angiomas in the temporal lobe being the most frequent type. Seizure onset among patients with vascular malformations occurred at a mean age of 22.2 years, the oldest age among the histopathological categories. Freedom from seizures 1 year after surgery occurred in 64.8% of patients with vascular malformations (73.0% of children and 63.4% of adults). Glial scars were found in 4.9% of specimens and † Three additional patients who did not have a glial scar as their primary histopathological diagnosis but had a glial scar as a second histopathological condition are included in this major category: one with a diagnosis of encephalitis, one with a mild malformation of cortical development, and one with focal cortical dysplasia. ‡ The percentages shown are the percentages within the age category (adults or children), with the exception of that given in the total row, which is the percentage of the 9523 total patients in the series. 
G H I
T h e ne w e ngl a nd jou r na l o f m e dicine were most often located in the temporal lobe or in multiple lobes (Table 3 ). The onset of seizures among patients with glial scars occurred at a mean age of 10.6 years, with a mean duration of epilepsy of 14.8 years before surgery. Glial scars occurred more often in men (61.0%) than in women (39.0%). The rate of postoperative freedom from seizures was numerically the lowest in this histopathological category (46.9%). A total of 1.5% of patients had a histopathological diagnosis of encephalitis, most commonly Rasmussen's encephalitis affecting multiple lobes. Seizure onset among patients with encephalitis occurred at a mean age of 10.1 years, and 50% of patients were seizure-free 1 year after surgery.
Discussion
In this series of approximately 10,000 specimens of brain tissue obtained during epilepsy surgery, the 10 most frequent histopathological diagnoses accounted for 86.7% of cases of drug-resistant epilepsy. The detailed diagnoses could be categorized into seven broad categories. Hippocampal sclerosis was the most frequent lesion, a finding consistent with results of studies involving smaller series of patients who have undergone epilepsy surgery. 8, 12, 13 Pathological diagnosis was aided by identification of anatomical landmarks, best appreciated in gross anatomical specimens. An international consensus recommendation for the procurement of brain tissue from patients with epilepsy on the basis of the identification of anatomical landmarks has recently been proposed by the ILAE Commission on Diagnostic Methods. 16 Among the patients with hippocampal sclerosis, 78.1% were younger than 18 years of age at disease onset; however, 88.7% of patients with this condition were adults at the time epilepsy surgery was performed, after a mean duration of epilepsy of 22.5 years. We suggested in a previous article that difficulties in identifying hippocampal sclerosis by means of routine MRI may contribute to this delay. 21 Our current analysis also suggests that patients with left hippocampal sclerosis had an earlier onset of epilepsy than did patients with right hippocampal sclerosis, but the differences were small and require confirmation.
Ganglioglioma and dysembryoplastic neuroepithelial tumors were the tumors most frequently found in our series, both in adults and in children. In contrast, infiltrating gliomas were uncommon, perhaps because patients with these tumors are usually not treated in specialized epilepsy surgery centers. Focal cortical dysplasias have been reported as being increasingly frequent in series of patients who have undergone epilepsy surgery. 8, 10, 11, 13 Cognitive delay and early onset of seizures have been associated with these lesions, but the clinical implications vary according to subtype.
14 Among the subtypes, the histopathological diagnosis of focal cortical dysplasia type I is particularly challenging, and we used immunohistochemical staining for NeuN 22 and nonphosphorylated neurofilament protein to identify cortical-layer abnormalities. A new category of focal cortical dysplasia type III was introduced in the 2011 consensus classification system of the ILAE, but its pathogenic basis and histopathological definition have not been clarified, 14 and this subtype was not considered to be a separate entity in our analysis.
In children and adults, 6.1% and 8.4%, respectively, of tissue samples had astrogliosis only and could not be categorized as having any conventional lesion type. This does not imply that the tissue was functionally normal, since 50.2% of patients with drug-resistant seizures before epilepsy surgery and unclassifiable tissue samples were seizure-free 12 months after surgery, which implicates the resected tissue in the genesis of the seizures. It is also possible that a molecular alteration that can decrease seizure threshold but is not apparent as an abnormality on light microscopy was an element involved in the conditions in this group of patients. 23 Ambiguous histopathological findings may also result from the inconsistent nature of neurosurgical sampling. Newly characterized histopathological entities in patients with focal epilepsies, such as oligodendroglial hyperplasia in white matter and hyaline protoplasmic astrocytopathy, may reduce the number of histopathologically nonlesional diagnoses in samples obtained during epilepsy surgery in the future. 24, 25 The limitations of our study include the retrospective data analysis and biases that are inherent in selecting patients with epilepsy for surgical treatment. Furthermore, some of the surgical procedures during which tissue was obtained involved disconnection procedures that do not typically allow for the microscopic identification of a brain lesion. The data from this large series add to the information on microscopically defined pathologic conditions in specimens obtained 
